Leadership Change

With its lead gene therapy nearing pivotal data, enGene installs a new chairman with a track record of commercial success, signaling a critical shift from R&D to market readiness.

With its first major acquisition and a new VP of Growth, specialty ink firm Nocopi Technologies is executing a deliberate strategy to scale its operations.

With a celebrated CEO out after just 14 months and a Mexico specialist in, Apollo Silver's leadership change raises questions about its future direction.

illumynt's hire of a Dell and Apple veteran isn't just a new SVP. It signals a strategic shift in managing the valuable, complex afterlife of AI hardware.

Foresight Enterprise VCT's new board appointments signal a dual focus on hands-on growth expertise and robust governance. What does this mean for its future?

With the hire of ANZ's former financial crime head, FTI Consulting is doubling down on a market facing intense regulatory pressure and evolving AI threats.

Infinity Natural Resources adds M&A architect Timothy Dugan to its board, a move analysts see as a clear signal of the shale driller's growth ambitions.

As Celldex nears pivotal data for its lead drug, the planned retirement of its long-serving CFO marks a strategic pivot toward becoming a commercial powerhouse.

CNA Canada's appointment of Malin Balasooriya is more than a new hire; it's a strategic move to master complex casualty and redefine its market position.

IntraNerve Neuroscience's new medical director appointments are more than a personnel update. They are a strategic signal of intent in a booming market.

As technology outpaces regulation, ASME appoints Suzanne McKillop to modernize engineering standards for an era of AI and immense global energy demands.

With a new president for its North American operations, Prosegur is betting big on an integrated security model where digital and physical defenses converge.

Oakworth Capital adds a 37-year EY veteran to its board. This isn't just a routine appointment; it's a calculated move to fuse global-tier oversight with regional agility.

The omnicommerce leader is betting its future on a 'human-in-the-loop' model, pairing its AI platform with veteran leadership to master retail's new era.

Health tech firm Ash adds Jon Stout and Matt Benton, who scaled AbleTo to a $470M acquisition, to conquer the competitive Medicare Advantage market.

James Bair's move from Google to Crowell & Moring shows a new trend: tech insiders are now the most valuable players in defending against DC scrutiny.

NOMAD Power Solutions poaches top talent to scale its transportable battery systems, betting big on solving the massive energy crunch created by AI data centers.

Arch Insurance promotes Nora Deveau to Chief Claims Officer, a move signaling a deep commitment to internal talent and strategic stability for the critical unit.

As Corrixr's novel CRISPR therapy nears human trials, the appointment of Seagen veteran Nancy Whiting signals a strategic shift from lab to market.

Facing a cash crunch and delisting threat, ENvue Medical stacks its board with clinical, AI, and finance heavyweights. Is it a lifeline or a last-ditch effort?